Emily Feld
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- Lung Cancer Research Studies
- CAR-T cell therapy research
-
- Lung Cancer Treatments and Mutations
Papers in
- Oncology 11
- Cancer Immunotherapy and Biomarkers 8
- CAR-T cell therapy research 2
- Lung Cancer Research Studies 2
-
- Lung Cancer Treatments and Mutations 3
- Co-authors
- Leora Horn (6 shared papers)Emily Castellanos (2 shared papers)Tara C. Mitchell (1 shared paper)Sharon Phillips (2 shared papers)Romany Johnpulle (1 shared paper)Shilin Zhao (1 shared paper)Ryan J. Sullivan (1 shared paper)Douglas B. Johnson (2 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)European Urology (2 papers)Clinical Lung Cancer (1 paper)Journal of Thoracic Oncology (1 paper)European Urology Oncology (1 paper)
- Partner nations
- United StatesIsraelUnited Kingdom
In The Last Decade
Emily Feld
16 papers receiving 444 citations
Peers
Comparison fields: 5 of 53
- Oncology 263
- Pulmonary and Respiratory Medicine 219
- Cancer Research 92
- Molecular Biology 164
- Immunology 39
Countries citing papers authored by Emily Feld
This map shows the geographic impact of Emily Feld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Feld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Feld more than expected).
Fields of papers citing papers by Emily Feld
This network shows the impact of papers produced by Emily Feld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Feld. The network helps show where Emily Feld may publish in the future.
Co-authors
The 25 scholars most cited alongside Emily Feld, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 209 | |
| 2 | 2016 | 75 | |
| 3 | 2019 | 32 | |
| 4 | 2019 | 32 | |
| 5 | 2018 | 25 | |
| 6 | 2021 | 21 | |
| 7 | 2016 | 12 | |
| 8 | 2023 | 11 | |
| 9 | 2019 | 10 | |
| 10 | 2021 | 7 | |
| 11 | 2016 | 4 | |
| 12 | 2017 | 3 | |
| 13 | 2019 | 2 | |
| 14 | 2017 | 2 | |
| 15 | 2019 | 2 | |
| 16 | 2024 | 1 | |
| 17 | 2022 | 1 |
About Emily Feld
Emily Feld is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Molecular Biology and Public Health, Environmental and Occupational Health, having authored 17 papers that have together received 449 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), Bladder and Urothelial Cancer Treatments (4 papers), Lung Cancer Treatments and Mutations (3 papers), Melanoma and MAPK Pathways (2 papers), Renal and related cancers (2 papers), CAR-T cell therapy research (2 papers), Urinary and Genital Oncology Studies (2 papers) and Lung Cancer Research Studies (2 papers). The work is most often cited by research in Oncology (263 citations), Pulmonary and Respiratory Medicine (219 citations), Cancer Research (92 citations), Molecular Biology (164 citations) and Immunology (39 citations). Emily Feld has collaborated with scholars based in United States, Israel and United Kingdom. Frequent co-authors include Leora Horn, Emily Castellanos, Tara C. Mitchell, Sharon Phillips, Romany Johnpulle, Shilin Zhao, Ryan J. Sullivan, Douglas B. Johnson, Elizabeth I. Buchbinder and Eirini Pectasides. Their work appears in journals such as Journal of Clinical Oncology, European Urology, Clinical Lung Cancer, Journal of Thoracic Oncology and European Urology Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.